Detalhe da pesquisa
1.
Predictors of excessive short-acting ß2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database.
Postepy Dermatol Alergol
; 40(6): 790-797, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38282873
2.
Biomarkers for predicting response to aspirin therapy in aspirin-exacerbated respiratory disease.
Clin Exp Allergy
; 51(8): 1046-1056, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33905579
3.
Artificial neural network identifies nonsteroidal anti-inflammatory drugs exacerbated respiratory disease (N-ERD) cohort.
Allergy
; 75(7): 1649-1658, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32012310
4.
The effect of levocetirizine and montelukast on clinical symptoms, serum level and skin expression of COX-1 and COX-2 enzymes in patients suffering from chronic autoimmune urticaria - a pilot study.
Postepy Dermatol Alergol
; 37(1): 73-80, 2020 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32467688
5.
Prevalence, risk factors and underdiagnosis of asthma in the general population aged over 60 years.
Postepy Dermatol Alergol
; 36(1): 86-91, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30858785
6.
Polish Society of Allergology statement on the diagnosis and treatment of severe, difficult-to-control bronchial asthma.
Postepy Dermatol Alergol
; 36(2): 147-157, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-31320846
7.
The position paper of the Polish Society of Allergology on climate changes, natural disasters and allergy and asthma.
Postepy Dermatol Alergol
; 35(6): 552-562, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-30618521
8.
Effectiveness of the Polish program for the treatment of severe allergic asthma with omalizumab: a single-center experience.
BMC Pulm Med
; 16(1): 61, 2016 Apr 26.
Artigo
Inglês
| MEDLINE | ID: mdl-27117315
9.
The effect of omalizumab on eosinophilic inflammation of the respiratory tract in patients with allergic asthma.
Pneumonol Alergol Pol
; 84(4): 232-43, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27435350
10.
Clinical and biochemical factors for response to aspirin desensitization in aspirin-induced asthma patients pilot study.
Przegl Lek
; 73(12): 781-5, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-29693971
11.
The whole-genome expression analysis of peripheral blood mononuclear cells from aspirin sensitive asthmatics versus aspirin tolerant patients and healthy donors after in vitro aspirin challenge.
Respir Res
; 16: 147, 2015 Dec 09.
Artigo
Inglês
| MEDLINE | ID: mdl-26646719
12.
Exacerbating factors induce different gene expression profiles in peripheral blood mononuclear cells from asthmatics, patients with chronic obstructive pulmonary disease and healthy subjects.
Int Arch Allergy Immunol
; 165(4): 229-43, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25634111
13.
Impact of chronic obstructive pulmonary disease (COPD) on patient's life and his family.
Pneumonol Alergol Pol
; 82(2): 82-95, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24615192
14.
POLASTMA--the Polish National Programme of Early Diagnosis and Therapy of Asthma.
Pneumonol Alergol Pol
; 82(6): 597-607, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25339572
15.
Loss of asthma control after cessation of omalizumab treatment: real life data.
Postepy Dermatol Alergol
; 31(1): 1-5, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24683390
16.
Omalizumab in pregnant women treated due to severe asthma: two case reports of good outcomes of pregnancies.
Postepy Dermatol Alergol
; 31(2): 104-7, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25097476
17.
Effectiveness of omalizumab in a patient with a life-threatening episode of bronchospasm and larynx angioedema after exposure to house dust.
Postepy Dermatol Alergol
; 31(1): 39-44, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24683397
18.
Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease.
Postepy Dermatol Alergol
; 36(2): 239-241, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-31320863
19.
Patient-Reported Outcome Measures in Atopic Dermatitis and Chronic Urticaria are Underused in Clinical Practice.
J Allergy Clin Immunol Pract
; 2024 Apr 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38604531
20.
Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 µg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 µg dry powder inhaler twice daily in patients with moderate asthma.
Pneumonol Alergol Pol
; 81(6): 527-36, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-24142782